Eprex
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
Recombinant human erythropoietin is the cornerstone of therapy for anemia associated with chronic kidney disease or…
INTRODUCTION
PDpoietin is a recombinant erythropoietin alfa that has been introduced by a manufacturer in Iran. We assessed the…
Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for…
Aim: Treatment of renal anaemia with epoetin is well established. However, epoetin is expensive. Biogeneric epoetin with proven…
BackgroundRecombinant human erythropoietin (EPO) is used for the treatment of last stage renal anemia. A new EPO preparation was…
OBJECTIVE
Patients with renal failure and undergoing hemo- (HD) or peritoneal dialysis are under oxidative stress which is…
In this study, a cohort of 109 patients with multiple myeloma were followed prospectively. Eight patients (7%) were found to have…
Intravenous recombinant human erythropoietin (Eprex Cilag) was used in 28 hemodialyzed children, treated in 3 French paediatric…